Intralipid 10%


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 21.3%
Nutritional Support 10.9%
Drug Therapy 9.1%
Product Used For Unknown Indication 8.7%
Crohn's Disease 7.8%
Malnutrition 7.4%
Metastatic Gastric Cancer 3.9%
Cardiac Failure 3.5%
Infection 3.5%
Intraoperative Care 3.5%
Meningitis Bacterial 2.6%
Pain 2.6%
Vomiting 2.6%
Brain Oedema 2.2%
Colitis Ulcerative 1.7%
Convulsion 1.7%
Exophthalmos 1.7%
Gastrointestinal Disorder Therapy 1.7%
Inflammation 1.7%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Device Related Infection 23.1%
Systemic Lupus Erythematosus Rash 12.8%
Toxic Epidermal Necrolysis 10.3%
Interstitial Lung Disease 7.7%
Foetal Death 5.1%
Thermal Burn 5.1%
Blood Potassium Decreased 2.6%
Death 2.6%
Dizziness 2.6%
Dyspnoea 2.6%
Foetal Exposure During Pregnancy 2.6%
Foetal Growth Restriction 2.6%
Hepatic Function Abnormal 2.6%
Liver Function Test Abnormal 2.6%
Lupus-like Syndrome 2.6%
Multiple Drug Overdose 2.6%
Oedema Peripheral 2.6%
Premature Delivery 2.6%
Sepsis 2.6%
Stevens-johnson Syndrome 2.6%
Concomitant
Product Used For Unknown Indication 19.0%
Drug Use For Unknown Indication 18.7%
Colitis Ulcerative 7.7%
Medical Diet 5.6%
Nutritional Support 5.2%
Prophylaxis 5.1%
Constipation 4.0%
In Vitro Fertilisation 4.0%
Insomnia 4.0%
Pneumonia 3.8%
Hypertension 3.4%
Infection 2.6%
Cancer Pain 2.4%
Gastrointestinal Haemorrhage 2.4%
Infection Prophylaxis 2.3%
Pain 2.3%
Immunosuppression 2.1%
Diarrhoea 1.9%
Colon Cancer Metastatic 1.7%
Crohn's Disease 1.7%
Colitis Ulcerative 12.3%
Sepsis 9.6%
Hypoglycaemia 8.2%
Vomiting 8.2%
Pleural Effusion 6.8%
Acute Hepatic Failure 5.5%
Hyperamylasaemia 5.5%
Interstitial Lung Disease 5.5%
Renal Failure Acute 5.5%
Platelet Count Decreased 4.1%
Rash 4.1%
Antepartum Haemorrhage 2.7%
Dyspnoea 2.7%
Fall 2.7%
Febrile Neutropenia 2.7%
Heart Rate Increased 2.7%
Hyperhidrosis 2.7%
Hyperkalaemia 2.7%
Hypoxia 2.7%
Influenza 2.7%

Drug Data